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Abstract
The noninvasive hemodynamic monitoring in patients with heart failure and chronic obstructive pulmonary disease was 
presented in this paper.
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Introduction
A common symptom reported by patients is dyspnea — 
a subjective feeling of lack of air, difficulty breathing or 
shortness of breath. The sensation of breathlessness can 
be experienced in many diseases. In an outpatient setting, 
differentiating between the causes of dyspnea can be 
a diagnostic challenge and is usually based on physical 
examination, laboratory tests and imaging tests available 
in primary healthcare settings. Outpatient non-invasive 
hemodynamic monitoring has the potential to predict exa-
cerbation of heart failure. Impedance cardiography (ICG) 
[1–3] and impedance scale are used in monitoring primary 
health care patients, which helps to differentiate between 
the causes of dyspnea in patients with heart failure (HF) 
and chronic obstructive pulmonary disease (COPD) [4, 5]. 
The aim of this study was to present the use of non-invasive 
monitoring of hemodynamic parameters in patients with 
COPD and coexisting HF [6].
ICG was used to assess hemodynamic parameters. 
This method is based on a change in the volume of blood 
pumped during the heart’s cycle, causing a change in 
electrical resistance. Hemodynamic indices are calculated 
from the changes in the chest resistance, heart rate and 
blood pressure. The following parameters were used for 
the study: thoracic fluid content (TFC) [1/kΩ], contractility 
index (HI, Heather index) [Ω × s–2], heart rate (HR) [1/min], 
stroke volume (SV) [ml] and cardiac output (CO) [l/min]; sy-
stemic vascular resistance (SVR) [dyn × s/cm5] was also 
calculated. The pre-ejection period (PEP) [ms] and the left 
ventricular ejection time (LVET) [ms] were determined from 
the curve, and the contractility index was calculated based 
on the PEP/LVET ratio — the so-called Weissler index [7].
Case report
A 64-year-old patient, diagnosed many years ago with COPD 
and HF, was treated on an outpatient basis due to increa-
sing dyspnea, decreased exercise tolerance and worsening 
of well-being. He was included in the AMULET program 
(“A new model of medical care with use of modern methods 
of non-invasive clinical assessment and telemedicine in 
patients with heart failure”) [8]. In the 6 months preceding 
the visit, he was hospitalized due to an exacerbation of HF. 
266
Folia Cardiologica 2020, vol. 15, no.3
www.journals.viamedica.pl/folia_cardiologica
The physical examination at the first visit showed a body 
weight of 75 kg and a height of 169 cm. The waist circum-
ference was 102 cm and the body mass index (BMI) was 
26.3 g/m2.
An electrocardiogram (ECG) showed a paced rhythm of 
80/min, and an X-ray of the chest showed an enlargement 
of the heart and visible signs of stasis. Echocardiography 
showed an increased diastolic left ventricular-diameter of 
73 mm, increased left atrial diameter of 59 mm and a left 
ventricular ejection fraction reduced to 23%.
The following results were obtained in laboratory tests: 
B-type natriuretic peptide (BNP) — 524 pg/mL, ferritin — 
124 µg/L, iron — 37 µg/dL, thyroid-stimulating hormone 
(TSH) — 2 µg/L, white blood count (WBC) — 11 × 109/L, 
red blood count (RBC) — 3.3 × 1012/L, hemoglobin (Hb) — 
10 g/dL.
The patient underwent ICG three times at monthly in-
tervals. This study compares the results obtained during 
all the examinations (Figures 1, 2).
The functional status of the patient was assessed according 
to the modified Medical Research Council (mMRC) apnea 
scale at level 3, and heart failure was assessed according 
to the New York Heart Association (NYHA) at grade II–III. 
The medical history revealed COPD (cat. B), paroxysmal 
atrial fibrillation, mitral valve insufficiency, chronic kidney 
disease (stage G3b), arterial hypertension, type 2 diabe-
tes, mixed hyperlipidemia, Mallory-Weiss syndrome. The 
patient underwent the following procedures: percutaneous 
coronary intervention (PCI) of the left posterolateral branch 
(LPL) from the circumflex artery (Cx) (coated stent), PCI of 
the left anterior descending (LAD) (coated stent) and im-
plantation of a resynchronization pacemaker. The patient 
denied alcohol consumption; however, he had smoked 
a pack of cigarettes a day for 50 years (50 pack-years), but 
had not smoked for the last 6 months. Pharmacotherapy 
during stabilization state included: amiodarone, metoprolol, 
potassium chloride, metformin, rivaroxaban, torasemide, 
ramipril, budesonide, and iprathiopium bromide.
Figure 1A–D. Preload [thoracic fluid content (TFC)] and myocardial contractility in a patient with heart failure and chronic obstructive 
pulmonary disease; TFCI — thoracic fluid content index; PEP — pre-ejection period; LVET — left ventricle ejection time; STR (systolic times 
ratio) — contractility coefficient/Weissler index
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The assessment of the cardiovascular system was ba-
sed on the analysis of changes in preload, myocardial con-
tractility, CO and afterload characterized by SVR. Thoracic 
fluid content decreased slightly on the second examination 
and increased significantly on the third visit. Relative prelo-
ad changes were determined using the ΔTFC. Compared to 
the first examination, the result obtained in the third visit 
increased by 11.94%.
Cardiac contractility was assessed by HI and the 
PEP/LVET ratio. It was noticed that HI was 5 times lower 
than the lower limit of normal — it oscillated between 
4.8 and 3.9. The relative decrease in contractility be-
tween Visit 1 and Visit 3 was 18.75%. The contractility 
abnormalities are also reflected in the increase in the 
Weissler index. According to Czaplicki et al. [7] the PEP/ 
/LVET ratio is a sensitive, classic indicator of myocar-
dial contractility. There was a clear increase in the va-
lue of Weissler index during the third examination. The 
relative deterioration reflected in the increase of this 
index, was 27.14% [7]. Systemic vascular resistance was 
within normal limits.
The obtained picture of hemodynamic changes indi-
cated that the cardiac pump function was preserved de-
spite critical disturbances in contractility. Presumably, the 
preservation of cardiovascular function resulted from the 
change in preload, in accordance with the Frank-Starlig 
law. Studies suggest that a slight increase in preload may 
cause a breakdown in cardiac contractility and pump fun-
ction [7]. Based on the telephone interview, information 
was obtained about the patient’s death.
Figure 2A–D. Stroke volume (SV), cardiac output (CO), and systemic vascular resistance (SVR) in a patient with heart failure and chronic 
obstructive pulmonary disease; SVI — stroke volume index; CI — cardiac index; SVRI — systemic vascular resistance index
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the causes of clinical deterioration. Examination with the 
use of ICG in an outpatient setting may be performed by 
mid-level medical staff.
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Summary
The analysis of the results presented above shows that the 
deterioration of the patient’s condition was mainly due to he-
modynamic disturbances, and not to exacerbation of COPD.
The presented application of non-invasive cardiovascu-
lar examination in patients with coexisting HF and COPD 
may provide information useful for differentiating between 
Streszczenie
W pracy przedstawiono zastosowanie nieinwazyjnej oceny hemodynamicznej u chorego z niewydolnością serca i prze-
wlekłą obturacyjną chorobą płuc.
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